Business Context and Reporting Period
Company: Aspen Aerogels, Inc. (NYSE: ASPN)
Filing Type: Form 8-K (Current Report)
Report Date: July 29, 2021
Reporting Period: Second Quarter 2021 (ended June 30, 2021)
This filing serves as a notification of the company's announcement of financial results for the second quarter of 2021 and related business developments. The detailed financial data and management commentary are contained in the attached press release (Exhibit 99.1), which is incorporated by reference.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.1) but are not present in the source text provided for this summary.
Material Changes
The filing indicates that the company announced its financial results and discussed business developments for the quarter ended June 30, 2021. Specific details regarding material changes versus the prior comparable period are not included in the text of this Form 8-K.
Guidance, Outlook, and Risks
- Financial Outlook: The filing explicitly incorporates the "2021 Financial Outlook" from the attached press release under Item 7.01 (Regulation FD Disclosure). Specific guidance figures are not listed in this document.
- Forward-Looking Statements: The filing notes the inclusion of a forward-looking statement disclaimer at the end of the press release.
- Risks and Contingencies: No specific risks or contingencies are detailed in the text of this Form 8-K; they are presumed to be addressed in the incorporated press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2021 revenue, net income, and cash flow figures.
- Verify the "2021 Financial Outlook" section in the press release for updated guidance.
- Confirm the details of "business developments" mentioned in the announcement.
- Check the forward-looking statement disclaimer in the press release for specific risk factors.